ClinPharm Consulting Expanding to Accommodate Increased Demand for Pharmacokinetic Services
ClinPharm Consulting has moved into new offices in RTP and is hiring more employees to accommodate an expanding portfolio of clients and projects.
"We are experiencing high demand for our expertise in pharmacokinetics and overall clinical pharmacology drug development services,” said Chief Scientific Officer M. Alexander Shaw, Ph.D., adding, "Our complete knowledge of clinical pharmacology and high-quality scientific writing is paying dividends for our clients and their drug pipelines.”
According to Dr. Shaw, small biopharmaceutical companies with minimal R&D infrastructure as well as mid-sized and large pharmaceutical companies are seeking access to the firm’s expertise with both traditional and population PK capabilities at an affordable cost.
In response to its increase in clientele, ClinPharm Consulting has secured a larger office space that will allow for further expansion and additional staff. The company is actively refining its internal processes and structure to accommodate new employees, while ensuring continued focus on quality, customer service, and value.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
